Iovance Biotherapeutics was the first drug developer to win FDA approval of an immune cell/T-cell therapy. The underlying ...

AstraZeneca advances its ambition to redefine cancer care with new data across its diverse, industry-leading portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress, ...

Providence Cancer Institute’s executive medical director, Bryan Bell, M.D., D.D.S, FACS, FRCS(Ed), recently discussed recent ...

Primary overall survival analysis from the Phase 3 monarchE study of Verzenio (abemaciclib) in HR+HER2-, node-positive, high-risk early breast cancer to ...

Medical artificial intelligence (AI) company Lunit announced on October 13 that it will present three studies on predicting immunotherapy response ...